Technology | PET-CT | October 05, 2016

GE Healthcare Discovery MI PET/CT Improves Detection of Small Lesions

Digital PET/CT system helps clinicians diagnose and stage disease earlier

GE Healthcare, Discovery MI PET/CT system, FDA clearance, RSNA 2016

October 5, 2016 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Discovery MI digital positron emission tomography (PET)/computed tomography (CT) system and shared a series of first clinical images. Built with technology allowing significantly better small lesion detectability, Discovery MI can help clinicians in their efforts to diagnose and stage disease earlier.

The first unit was installed at the Stanford University School of Medicine, Stanford, Calif.  

Discovery MI was created to help clinicians achieve their primary goal of diagnosing and staging disease earlier and to better guide their treatment strategies. It also enables more compelling research with more novel, faster decaying tracers. A key component in delivering these desired outcomes is Discovery MI’s LightBurst Digital Detector. This detector delivers up to two times improvement in volumetric resolution, enabling small lesion detectability, and has the highest NEMA sensitivity of any time-of-flight (TOF)/PET system in the industry, according to GE.

Discovery MI may also enhance clinicians’ diagnostic service offerings in oncology and expand PET’s impact in neurology, cardiology and beyond. These expanded capabilities are enabled by the ability to increase low-yield tracer capability with protocols that reduce dose by up to 50 percent, allowing clinicians to pursue research without impacting image quality.

This system also features diagnostic CT innovations helping to deliver 100 percent better spatial resolution, with no increase in image noise with ASiR-V. And with Smart Metal Artifact Reduction (MAR), Discovery MI helps virtually eliminate streaks and shadows from metal artifacts, saving valuable time previously spent correcting images, increasing the number of successful scans for patients.

For more information: www.gehealthcare.com

Related Content

Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
The Siemens Biograph Vision PET-CT system was released in mid-2018.

The Siemens Biograph Vision PET-CT system was released in mid-2018.

Feature | Nuclear Imaging | September 07, 2018 | By Dave Fornell
Nuclear imaging technology for both single photon emission computed tomography (SPECT) and positron emission tomography...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Brain Study of 62,454 Scans Identifies Drives of Brain Aging
News | SPECT Imaging | August 27, 2018
In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain single photon...
Abnormal Protein Concentrations Found in Brains of Military Personnel With Suspected CTE

Researchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encephalopathy in living patients. In this image, warmer colors indicate a higher concentration of the tracer, which binds to abnormal proteins in the brain. Credit UCLA Health.

News | PET Imaging | August 24, 2018
August 24, 2018 — In a small study of
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
Novel PET Imaging Method Could Track and Guide Type 1 Diabetes Therapy
News | PET Imaging | August 03, 2018
Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The...
Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...